bacopa monnieri + nardostachys jatamansi

This water-based herbal combination, developed by The Stanley Medical Research Institute, consists of extracts from *Bacopa monnieri* (BM) and *Nardostachys jatamansi* (NJ). It was investigated as an oral treatment for schizophrenia, with the hypothesis that it would provide comparable efficacy to modern atypical antipsychotics like olanzapine while maintaining a superior safety profile for long-term use. *Bacopa monnieri* is traditionally recognized in Ayurvedic medicine for its potential to repair damaged neurons by enhancing kinase activity and nerve impulse transmission, alongside its antioxidant properties. *Nardostachys jatamansi* contributes neuroprotective and potentially sedative effects. The combination was evaluated in a Phase 2 clinical trial (NCT00483964) to assess its safety and efficacy in managing schizophrenia symptoms.

Other names

BM + NJ combinationSMRI herbal combinationAyurvedic herbal preparation